Modulation of high affinity ATP-dependent cyclic nucleotide transporters by specific and non-specific cyclic nucleotide phosphodiesterase inhibitors

European Journal of Pharmacology

Volumn 745, Issue , 2014, Pages 249-253

  Aronsen, Lena ^a,b   Orvoll, Elin ^a   Lysaa, Roy ^a   Ravna, Aina W ^a   Sager, Georg ^a,b  

^a UNIVERSITY OF TROMSØ   (Norway)

^b UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

ABC transporters; ABCC5; PDE inhibitors cGMP cAMP; PDE5

Indexed keywords

EID: 84949116278     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.10.051     Document Type: Article

References (41)

1. S.P.H. Alexander, H.E. Benson, E. Faccenda, A.J. Pawson, J.L. Sharman, M. Spedding, J.A. Peters, and A.J. Harmar The concise guide to pharmacology 2013/14: transporters Br. J. Pharmacol. 170 2013 1706 1796
2. S.A. Ballard, C.J. Gingell, K. Tang, L.A. Turner, M.E. Price, and A.M. Naylor Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes J. Urol. 159 1998 2164 2171
3. J.A. Beavo, and L.L. Brunton Cyclic nucleotide research - still expanding after half a century Nat. Rev. Mol. Cell Biol. 3 2002 710 718
4. A.T. Bender, and J.A. Beavo Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacol. Rev. 58 2006 488 520
5. K.B. Cahill, J.H. Quade, K.L. Carleton, and R.H. Cote Identification of amino acid residues responsible for the selectivity of tadalafil binding to two closely related phosphodiesterases, PDE5 and PDE6 J. Biol. Chem. 287 2012 41406 41416
6. P. Cano-Soldado, and M. Pastor-Anglada Transporters that translocate nucleosides and structural similar drugs: structural requirements for substrate recognition Med. Res. Rev. 32 2012 428 457
7. S. Cheepala, J.S. Hulot, J.A. Morgan, Y. Sassi, W. Zhang, A.P. Naren, and J.D. Schuetz Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters Annu. Rev. Pharmacol. Toxicol. 53 2013 231 253
8. Z.S. Chen, K. Lee, and G.D. Kruh Transport of cyclic nucleotides and estradiol 17-beta-d-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine J. Biol. Chem. 276 2001 33747 33754
9. 50) of an enzymatic reaction Biochem. Pharmacol. 22 1973 3099 3108
10. T.C. Chou Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands J. Theor. Biol. 39 1976 253 276
11. S. Copsel, C. Garcia, F. Diez, M. Vermeulem, A. Baldi, L.G. Bianciotti, F.G. Russel, C. Shayo, and C. Davio Multidrug resistance protein 4 (MRP4/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation J. Biol. Chem. 286 2011 6979 6988
12. C.J. de Wolf, H. Yamaguchi, I. van der Heijden, P.R. Wielinga, S.L. Hundscheid, N. Ono, G.L. Scheffer, H.M. de, J.D. Schuetz, J. Wijnholds, and P. Borst cGMP transport by vesicles from human and mouse erythrocytes FEBS J. 274 2007 439 450
13. P.R. Ding, A.K. Tiwari, S. Ohnuma, J.W. Lee, X. An, C.L. Dai, Q.S. Lu, S. Singh, D.H. Yang, T.T. Talele, S.V. Ambudkar, and Z.S. Chen The phosphodiesterase-5 inhibitor vardenafil is a potent inhibitor of ABCB1/P-glycoprotein transporter PloS One 6 2011 e19329
14. G.L. Ellman, K.D. Courtney, V. Andres jr, and R.M. Featherstone A new and rapid colorometric determination of acetylcholinesterase activity Biochem. Pharmacol. 7 1961 88 95
15. S.H. Francis, K.R. Sekhar, H. Ke, and J.D. Corbin Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds B.B. Fredholm, Methylxanthines 2011 Springer Verlag Berlin Heidelberg 93 133
16. A.M. Hartz, and B. Bauer ABC transporters in the CNS - an inventory Curr. Pharm. Biotechnol. 12 2011 656 673
17. G. Jedlitschky, B. Burchell, and D. Keppler The multidrug resistance protein 5 functions as an ATP-dependent export pump for cyclic nucleotides J. Biol. Chem. 275 2000 30069 30074
18. N.N. Kim, Y.H. Huang, I. Goldstein, E. Bischoff, and A.M. Traish Inhibition of cyclic GMP hydrolysis in human corpus cavernosum smooth muscle cells by vardenafil, a novel, selective phosphodiesterase type 5 inhibitor Life Sci. 69 2001 2249 2256
19. A. Klokouzas, C.P. Wu, H.W. van Veen, M.A. Barrand, and S.B. Hladky cGMP and glutathione-conjugate transport in human erythrocytes Eur. J. Biochem. 270 2003 3696 3708
20. T.T. Lang, J.D. Young, and C.E. Cass Interactions of nucleoside analogs, caffeine, and nicotine with human concentrative nucleoside transporters 1 and 2 stably produced in a transport-defective human cell line Mol. Pharmacol. 65 2004 925 933
21. C. Lugnier Cyclic nucleotide phosphodiesterase (PDE) superfamily: a new target for the development of specific therapeutic agents Pharmacol. Ther. 109 2006 366 398
22. C. Lugnier, P. Schoeffter, B.A. Le, E. Strouthou, and J.C. Stoclet Selective inhibition of cyclic nucleotide phosphodiesterases of human, bovine and rat aorta Biochem. Pharmacol. 35 1986 1743 1751
23. D.H. Maurice, H. Ke, F. Ahmad, Y. Wang, J. Chung, and V.C. Manganiello Advances in targeting cyclic nucleotide phosphodiesterases Nat. Rev. Drug Discov. 13 2014 290 314
24. A.L. McCall, W.R. Millington, and R.J. Wurtman Blood-brain barrier transport of caffeine: dose-related restriction of adenine transport Life Sci. 31 1982 2709 2715
25. R.B. Moreland, I. Goldstein, and A. Traish Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells Life Sci. 62 1998 L-18
26. C.E. Muller, and K.A. Jacobson Xanthines as adenosine receptor antagonists B.B. Fredholm, Methylxanthines 2011 Springer Verlag Berlin Heidelberg 151 199
27. E. Orvoll, R.A. Lysaa, A.W. Ravna, and G. Sager Misoprostol and the sildenafil analog (PHAR- 0099048) modulate cellular efflux of cAMP and cGMP differently Pharmacol. Pharm. 4 2013 104 109
28. M. Rius, J. Hummel-Eisenbeiss, and D. Keppler ATP-dependent transport of Leukotrienes B4 and C4 by the multidrug resistance protein ABCC4 (MRP4) J. Pharmacol. Exp. Ther. 324 2008 86 94
29. G. Sager, E. Orvoll, R. Lysaa, I. Kufareva, R. Abagyan, and A.W. Ravna Novel cGMP efflux inhibitors - Identified by virtual ligand screening (VLS) and confirmed by experimental studies J. Med. Chem. 55 2012 3049 3057
30. R. Savai, S.S. Pullamsetti, G.A. Banat, N. Weissmann, H.A. Ghofrani, F. Grimminger, and R.T. Schermuly Targeting cancer with phosphodiesterase inhibitors Expert Opin. Investig. Drugs 19 2010 117 131
31. W. Schaper Dipyridamole, an underestimated vascular protective drug Cardiovasc. Drugs Ther. 19 2005 357 363
32. Z. Shi, A.K. Tiwari, S. Shukla, R.W. Robey, S. Singh, I.W. Kim, S.E. Bates, X. Peng, I. Abraham, S.V. Ambudkar, T.T. Talele, L.W. Fu, and Z.S. Chen Sildenafil reverses ABCB1- and ABCG2-mediated chemotherapeutic drug resistance Cancer Res. 71 2011 3029 3041
33. T.L. Steck, R.S. Weinstein, J.H. Straus, and D.F.H. Wallach Inside-out cell membrane vesicles: preparation and purification Science 168 1970 255 257
34. E. Sundkvist, R. Jaeger, and G. Sager Pharmacological characterization of the ATP-dependent low K(m) guanosine 3′,5′-cyclic monophosphate (cGMP) transporter in human erythrocytes Biochem. Pharmacol. 63 2002 945 949
35. S. Tanaka, S. Uchida, N. Inui, K. Takeuchi, H. Watanabe, and N. Namiki Simultaneous LC-MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 substrate drugs and their metabolites Biol. Pharm. Bull. 37 2014 18 25
36. I.V. Turko, S.A. Ballard, S.H. Francis, and J.D. Corbin Inhibition of cyclic GMP-binding cyclic GMP-specific phosphodiesterase (Type 5) by sildenafil and related compounds Mol. Pharmacol. 56 1999 124 130
37. R.A. van Aubel, P.H. Smeets, J.J. Van Den Heuvel, and F.G. Russel Human organic anion transporter MRP4 (ABCC4) is an efflux pump for the purine end metabolite urate with multiple allosteric substrate binding sites Am. J. Physiol. Renal Physiol. 288 2005 F327 F333
38. P. Wang, P. Wu, J.G. Myers, A. Stamford, R.W. Egan, and M.M. Billah Characterization of human, dog and rabbit corpus cavernosum type 5 phosphodiesterases Life Sci. 68 2001 1977 1987
39. P.R. Wielinga, H.I. van der, G. Reid, J.H. Beijnen, J. Wijnholds, and P. Borst Characterization of the MRP4-and MRP5-mediated transport of cyclic nucleotides from intact cells J. Biol. Chem. 278 2003 17664 17671
40. H.G. Wittgen, J.J. Van Den Heuvel, E. Krieger, G. Schaftenaar, F.G. Russel, and J.B. Koenderink Phenylalanine 368 of multidrug resistance-associated protein 4 (MRP4/ABCC4) plays a crucial role in substrate-specific transport activity Biochem. Pharmacol. 84 2012 366 373
41. C.P. Wu, H. Woodcock, S.B. Hladky, and M.A. Barrand cGMP (guanosine 3′,5′-cyclic monophosphate) transport across human erythrocyte membranes Biochem. Pharmacol. 69 2005 1257 1262